Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 18.15

(-0.55%)

Net Income Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual net income in 2023 was -2.64 Million TWD , down -127.72% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly net income in 2024 Q2 was -529 Thousand TWD , up 90.67% from previous quarter.
Welgene Biotech Co.,Ltd. reported an annual net income of 9.55 Million TWD in 2022, down -30.29% from previous year.
Welgene Biotech Co.,Ltd. reported an annual net income of 13.7 Million TWD in 2021, down -53.98% from previous year.
Welgene Biotech Co.,Ltd. reported a quarterly net income of -5.66 Million TWD for 2024 Q1, down -106.64% from previous quarter.
Welgene Biotech Co.,Ltd. reported a quarterly net income of -2.74 Million TWD for 2023 Q4, down -219.32% from previous quarter.

Annual Net Income Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Net Income of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Net Income	Net Income Growth
2023	-2.64 Million TWD	-127.72%
2022	9.55 Million TWD	-30.29%
2021	13.7 Million TWD	-53.98%
2020	29.77 Million TWD	-3.55%
2019	30.87 Million TWD	8.93%
2018	28.34 Million TWD	19.82%
2017	23.65 Million TWD	477.72%
2016	4.09 Million TWD	-80.77%
2015	21.29 Million TWD	0.9%
2014	21.1 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-529 Thousand TWD	90.67%
2024 Q1	-5.66 Million TWD	-106.64%
2023 Q4	-2.74 Million TWD	-219.32%
2023 FY	-2.64 Million TWD	-127.72%
2023 Q1	-4.9 Million TWD	-91.56%
2023 Q2	5.85 Million TWD	219.46%
2023 Q3	-859 Thousand TWD	-114.67%
2022 Q2	12.49 Million TWD	345.18%
2022 Q4	-2.55 Million TWD	-154.29%
2022 Q3	4.71 Million TWD	-62.26%
2022 Q1	-5.09 Million TWD	-137.56%
2022 FY	9.55 Million TWD	-30.29%
2021 Q3	-103 Thousand TWD	-101.78%
2021 FY	13.7 Million TWD	-53.98%
2021 Q4	13.56 Million TWD	13268.93%
2021 Q1	-5.53 Million TWD	-159.25%
2021 Q2	5.77 Million TWD	204.37%
2020 FY	29.77 Million TWD	-3.55%
2020 Q4	9.33 Million TWD	0.34%
2020 Q3	9.3 Million TWD	0.35%
2020 Q2	9.27 Million TWD	397.96%
2020 Q1	1.86 Million TWD	-85.26%
2019 FY	30.87 Million TWD	8.93%
2019 Q4	12.62 Million TWD	22.03%
2019 Q3	10.34 Million TWD	162.23%
2019 Q2	3.94 Million TWD	0.0%
2019 Q1	3.94 Million TWD	-70.0%
2018 Q2	1.01 Million TWD	0.0%
2018 FY	28.34 Million TWD	19.82%
2018 Q1	1.01 Million TWD	-86.62%
2018 Q3	13.15 Million TWD	1194.69%
2018 Q4	13.15 Million TWD	0.0%
2017 Q3	7.59 Million TWD	79.31%
2017 Q2	4.23 Million TWD	0.0%
2017 Q4	7.59 Million TWD	0.0%
2017 FY	23.65 Million TWD	477.72%
2017 Q1	4.23 Million TWD	4.91%
2016 FY	4.09 Million TWD	-80.77%
2016 Q4	4.03 Million TWD	0.0%
2016 Q3	4.03 Million TWD	302.92%
2016 Q2	-1.98 Million TWD	0.0%
2016 Q1	-1.98 Million TWD	0.0%
2015 FY	21.29 Million TWD	0.9%
2014 FY	21.1 Million TWD	0.0%

Peer Net Income Comparison of Welgene Biotech Co.,Ltd.

Name	Net Income	Net Income Difference
BIONET Corp.	78.39 Million TWD	103.378%
DIVA Laboratories, Ltd.	73.61 Million TWD	103.597%
Genetics Generation Advancement Corp.	28.56 Million TWD	109.27%
Puriblood Medical Co., Ltd.	-51.59 Million TWD	94.868%
TFBS Bioscience Inc.	4.9 Million TWD	153.942%